Compare FRGE & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRGE | RXST |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.4M | 524.6M |
| IPO Year | N/A | 2021 |
| Metric | FRGE | RXST |
|---|---|---|
| Price | $44.57 | $12.04 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 11 |
| Target Price | ★ $31.00 | $11.30 |
| AVG Volume (30 Days) | 451.9K | ★ 876.6K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $92,884,000.00 | ★ $142,085,000.00 |
| Revenue This Year | $33.10 | N/A |
| Revenue Next Year | $24.07 | $4.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.40 | 10.75 |
| 52 Week Low | $6.60 | $6.32 |
| 52 Week High | $44.76 | $38.64 |
| Indicator | FRGE | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 85.45 | 56.92 |
| Support Level | $44.30 | $12.07 |
| Resistance Level | $44.75 | $13.14 |
| Average True Range (ATR) | 0.14 | 0.67 |
| MACD | -0.75 | -0.11 |
| Stochastic Oscillator | 67.27 | 40.70 |
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.